Glaxosmithkline Share News (GSK)

Isis Pharma Earns USD1.5 Million From Glaxo For ISIS-GSK4 Rx

UK Dividends Calendar - Week Ahead

UK Dividends Calendar - Week Ahead

Glaxo Announces USD5M Fund For Bioelectronics Research

UK Dividends Calendar - Week Ahead

UK Dividends Calendar - Week Ahead

UPDATE 1-Roche, GSK melanoma pill combinations look similar in showdown

* Roche set to compete with established GSK combination * Similar results with BRAF/MEK cocktails in melanoma * Different side effects may determine choice of regimen * Shares in Roche's biotech partner Exelixis jump 20 pct (Adds Exelixis share price jump, more on treatment de

Glaxo Phase III Tafinlar Study Shows Survival Rate Of 45% At Two Years

RPT-Scientists grapple with ethics in rush to release Ebola vaccines

(Repeats story, text unchanged) * Ebola emergency demands speed, more risk in vaccine tests * Vaccines will be evaluated at same time as being deployed * Issues of placebos and control groups need consideration * WHO sees small-scale vaccine use in W. Africa by Jan 2015Read more

Roche, GSK cancer pill combos look similar in showdown

* Similar results with BRAF/MEK combinations in melanoma * Different side effects may determine choice of regimen By Ben Hirschler MADRID, Sept 29 (Reuters) - Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline have yielded similar results in separate clinica

Scientists grapple with ethics in rush to release Ebola vaccines

* Ebola emergency demands speed, more risk in vaccine tests * Vaccines will be evaluated at same time as being deployed * Issues of placebos and control groups need consideration * WHO sees small-scale vaccine use in W. Africa by Jan 2015 By Kate Kelland, Health and Scienc

Failed cancer vaccines might live again with new immune drugs

By Ben Hirschler MADRID, Sept 28 (Reuters) - Using vaccines to fight cancer is a field littered with failures but experts believe it is possible the approach could get a new lease of life if such shots are combined with a new class of drugs called checkpoint inhibitors. Unlike traditi

UPDATE 1-WHO sees small-scale use of experimental Ebola vaccines in January

* WHO focused on candidate GSK, Newlink shots if shown safe * Few hundred doses of ZMapp expected by year-end * Blood transfusions, serum from survivors offer best hope (updates with new death toll in 2nd para) By Stephanie Nebehay GENEVA, Sept 26 (Reuters) - The World H

WHO sees small-scale use of experimental Ebola vaccines in January

* WHO focused on candidate GSK, Newlink shots if shown safe * Few hundred doses of ZMapp expected by year-end * Blood transfusions, serum from survivors offer best hope By Stephanie Nebehay GENEVA, Sept 26 (Reuters) - The World Health Organisation (WHO) said on Friday it e

UK Dividends Calendar - Week Ahead